These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 15839918

  • 1. Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.
    Gårdmark T, Wester K, De la Torre M, Carlsson J, Malmström PU.
    BJU Int; 2005 May; 95(7):982-6. PubMed ID: 15839918
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer.
    Yamada Y, Naruse K, Nakamura K, Aoki S, Taki T, Tobiume M, Zennami K, Katsuda R, Inoue Y, Noguchi H, Honda N.
    Oncol Rep; 2007 Jul; 18(1):3-7. PubMed ID: 17549338
    [Abstract] [Full Text] [Related]

  • 5. Expression of HER2/neu in primary and metastatic breast cancer.
    Tuziak T, Olszewski WP, Olszewski W, Pieńkowski T.
    Pol J Pathol; 2001 Jul; 52(1-2):21-6. PubMed ID: 11505677
    [Abstract] [Full Text] [Related]

  • 6. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
    Fleischmann A, Rotzer D, Seiler R, Studer UE, Thalmann GN.
    Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H, Yamada Y, Naruse K, Nakamura K, Aoki S, Taki T, Tobiume M, Zennami K, Katsuda R, Honda N.
    Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
    [Abstract] [Full Text] [Related]

  • 10. Novel approach of human epidermal growth factor receptor 2 detection in noninvasive and invasive transitional cell carcinoma of the bladder.
    Hauser-Kronberger C, Peham K, Grall J, Rausch W, Hutarew G, Dietze O.
    J Urol; 2006 Mar; 175(3 Pt 1):875-80; discussion 880. PubMed ID: 16469569
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
    Wei Q, Sheng L, Shui Y, Hu Q, Nordgren H, Carlsson J.
    Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
    [Abstract] [Full Text] [Related]

  • 15. Expression of the epidermal growth factor receptor family in normal and malignant urothelium.
    Røtterud R, Nesland JM, Berner A, Fosså SD.
    BJU Int; 2005 Jun; 95(9):1344-50. PubMed ID: 15892828
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer.
    Horiguchi J, Koibuchi Y, Iijima K, Yoshida T, Takata D, Rokutanda N, Nagaoka R, Oyama T, Iino Y, Morishita Y.
    Oncol Rep; 2005 Nov; 14(5):1109-16. PubMed ID: 16211272
    [Abstract] [Full Text] [Related]

  • 18. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
    Mihai R, Stevens J, McKinney C, Ibrahim NB.
    Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
    [Abstract] [Full Text] [Related]

  • 19. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.
    Margulis V, Shariat SF, Ashfaq R, Thompson M, Sagalowsky AI, Hsieh JT, Lotan Y.
    J Urol; 2007 Mar; 177(3):1163-8. PubMed ID: 17296438
    [Abstract] [Full Text] [Related]

  • 20. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.